14 Jan 2026
Productivity Commission pushes stronger hospital–PHN partnerships
Closer and more formal collaboration between hospitals and Primary Health Networks (PHNs) is needed to improve health outcomes and system efficiency, according to the Productivity Commission.
14 Jan 2026
Daily weight-loss pill approved in US, experts urge caution
A new daily pill for weight management has been approved in the United States, raising hopes it could offer a more accessible alternative to injectable treatments — though experts say long-term evidence is still limited.
14 Jan 2026
Therapeutic Guidelines Release Major Antibiotic Update
Australia’s Therapeutic Guidelines has released its final antibiotic update for 2025, introducing significant changes across several key clinical areas, including perinatal infections, surgery, skin infections and wound management.
13 Jan 2026
ECG Rebates for GPs Back From March 2026
GPs will be able to claim MBS item 11714 for electrocardiograms (ECGs) from 1 March 2026, reversing a five-year-old funding cut.
13 Jan 2026
Study Warns Weight-Loss Drugs Don’t Deliver Lasting Results Alone
Weight-loss medications may help people shed kilos initially, but most patients regain the weight within two years of stopping treatment, according to a major international analysis.
13 Jan 2026
PBS Kicks Off 2026 With New and Expanded Medicine Listings
Australians are seeing the first new Pharmaceutical Benefits Scheme (PBS) medicine listings for 2026, including expanded access to an arthritis treatment for children and new therapies for rare liver disease and multiple sclerosis.
12 Jan 2026
Government Moves Toward PBS Listing for Wegovy
The Federal Government has begun steps toward listing the weight-loss medicine Wegovy on the Pharmaceutical Benefits Scheme (PBS), following a recommendation from the Pharmaceutical Benefits Advisory Committee (PBAC).
12 Jan 2026
PBS Listings Deliver Major Savings for Women’s Health
New figures show hundreds of thousands of Australian women are paying less for essential medicines after new women’s health treatments were added to the Pharmaceutical Benefits Scheme (PBS).
12 Jan 2026
Spike in Bulk‑Billing GP Clinics — but Patient Costs Are Rising Too
New data from online health directory Cleanbill’s annual Blue Report shows a big jump in the number of general practices offering full bulk‑billing — but also a significant rise in out‑of‑pocket costs for patients who aren’t bulk‑billed.
19 Dec 2025
PBS move brings Wegovy closer for people with heart disease and obesity
Wegovy (semaglutide) is a step closer to being subsidised in Australia, after the Pharmaceutical Benefits Advisory Committee (PBAC) recommended it be listed on the PBS for some adults living with obesity and established cardiovascular disease.